Skip to main content
Clinical Trials/NCT05726968
NCT05726968
Completed
Phase 3

A Comparative Study on Three Different Doses of Intrathecal Hyperbaric Prilocaine With Fentanyl for Optimal Dose to be Used in Elderly Patients Undergoing Day Case Lower Abdominal and Urologic Surgeries.

Cairo University1 site in 1 country45 target enrollmentNovember 14, 2022

Overview

Phase
Phase 3
Intervention
Pilocaine 2% (1.5 ml) and 25 ug fentany
Conditions
Three Different Doses of Intrathecal Hyperbaric Prilocaine With Fentanyl
Sponsor
Cairo University
Enrollment
45
Locations
1
Primary Endpoint
Duration of motor Block in hours
Status
Completed
Last Updated
last year

Overview

Brief Summary

To compare the effects of using different doses of intrathecal hyperbaric prilocaine 2% combined with fentanyl 25 µg in patients scheduled for a day-case lower abdominal and urologic surgery in the geriatric patient population.

Detailed Description

* To evaluate the safety and effectiveness of spinal anaesthesia with hyperbaric Prilocaine 2% in a reduced dose (30mg) in combination with Fentanyl (25µg) in day-case lower abdominal and urologic surgeries in the geriatric population. * To compare between three different doses of prilocaine 2% in elderly patients undergoing day case lower abdominal and urologic surgeries. * To estimate the duration of stay in PACU and hospital stay with different doses of prilocaine 2% in elderly patients undergoing day case lower abdominal and urologic surgeries.

Registry
clinicaltrials.gov
Start Date
November 14, 2022
End Date
December 5, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ahmed Abdalla

Professor of Anesthesia &I.C.U and Pain Clinic, Cairo University

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Age (65 - 80)
  • ASA I - III
  • Both genders.
  • Height (1.60-1.90) m.
  • BMI (18.5-40) kg m-2
  • Scheduled for elective day-case lower abdominal or urologic procedures \< 90 minutes in duration under spinal anesthesia.
  • Type of surgery: Inguinal, femoral and incisional herniorrhaphies, bilateral varicocelectomies, hydrocelectomy, lymph node biopsies and mass excision biopsies, TURP surgery, Cystoscopies, ureteroscopy, bladder stone extraction, DJ insertion.

Exclusion Criteria

  • Patients requiring general anesthesia.
  • Operations requiring sensory block above T
  • Known or suspected coagulopathy (international normalised ratio \> 1.4), thrombocytopenia (platelet count \< 100,000).
  • Known peripheral neuropathy, neurological deficits or skeletal deformities.
  • Known allergy to prilocaine.
  • Infection at site of injection.
  • Patients' refusal to sign informed consent.
  • Patients 'not meet inclusion criteria.

Arms & Interventions

● Group P1 (N 15)

Patients assigned to this group will receive intrathecal 30 mg (1.5 ml) of prilocaine 2% (Takipril, prilocaine hydrochloride 20 mg/mL, hyperbar, Sintetica) + 25 ug fentanyl (0.5 ml).

Intervention: Pilocaine 2% (1.5 ml) and 25 ug fentany

● Group P2 (N 15)

Patient assigned to this group will receive intrathecal 40 mg (2 ml) of prilocaine 2% + 25 ug fentanyl (0.5 ml).

Intervention: Pilocaine 2% (1.5 ml) and 25 ug fentany

● Group P3 (N 15)

patient assigned to this group will receive intrathecal 50 mg (2.5 ml) of prilocaine 2% + 25 ug fentanyl (0.5 ml)

Intervention: Pilocaine 2% (1.5 ml) and 25 ug fentany

Outcomes

Primary Outcomes

Duration of motor Block in hours

Time Frame: Through Study Completion,an average of 1day

The primary outcome measure will be duration of motor Block in minutes, defined as the duration between intrathecal drug injection and time to unassisted ambulation or Bromage's score = 0 (no motor block).

Secondary Outcomes

  • Onset of motor block in minutes(Through Study Completion,an average of 1day)
  • Highest dermatomal level of sensory block.(Through Study Completion,an average of 1day)
  • Onset of sensory block in minutes(Through Study Completion,an average of 1day)
  • Motor block at the time of reaching highest sensory block.(through study completion,an average of 1day)
  • Full regression of sensory block(Through Study Completion,an average of 1day)
  • Duration of PACU stay(Through Study Completion,an average of 1day)
  • Time to reach to highest sensory block in minutes.(Through study completion,an average of 1day)
  • The incidence of adverse effects(Through Study Completion,an average of 1day)

Study Sites (1)

Loading locations...

Similar Trials